CITADEL ADVISORS LLC quarter change: USA Warrants, Reduced
In warrants (listed in the US), from the quarter ended 2025-12-31 to 2026-03-31, CITADEL ADVISORS LLC opened 9 positions, added to 8, reduced 22, sold out of 15 and left 2 unchanged. The largest increase in value was BRIACELL THERAPEUTICS CORP (+$1,048,759); the largest decrease was NUTRIBAND INC (-$85,019).
- BONE BIOLOGICS CORP: Country of operation —; Class *W EXP 10/13/202; Shares 2025-12-31 35,323; Shares 2026-03-31 29,752.
- NUTRIBAND INC: Country of operation —; Class *W EXP 99/99/999; Shares 2025-12-31 119,387; Shares 2026-03-31 95,709.
- TRISALUS LIFE SCIENCES INC: Country of operation —; Class *W EXP 08/10/202; Shares 2025-12-31 78,283; Shares 2026-03-31 65,190.
- GRABAGUN DIGITAL HLDGS INC: Country of operation —; Class *W EXP 99/99/999; Shares 2025-12-31 305,049; Shares 2026-03-31 304,758.
Two Form 13F-HR filings compared (SEC CIK 1423053): 2025-12-31 (filed 2026-02-17) and 2026-03-31 (filed 2026-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2025-12-31 | Shares 2026-03-31 | Share change | Value 2025-12-31 | Value 2026-03-31 | Value change |
|---|
BONE BIOLOGICS CORP
CUSIP 098070154 | — | *W EXP 10/13/202 | 35,323 | 29,752 | -5,571 | $547,507 | $684,296 | +$136,789 |
|---|
NUTRIBAND INC
CUSIP 67092M125 | — | *W EXP 99/99/999 | 119,387 | 95,709 | -23,678 | $192,213 | $107,194 | -$85,019 |
|---|
TRISALUS LIFE SCIENCES INC
CUSIP 89680M119 | — | *W EXP 08/10/202 | 78,283 | 65,190 | -13,093 | $129,167 | $78,228 | -$50,939 |
|---|
GRABAGUN DIGITAL HLDGS INC
CUSIP 38387Q113 | — | *W EXP 99/99/999 | 305,049 | 304,758 | -291 | $114,393 | $143,967 | +$29,574 |
|---|
GIGCAPITAL7 CORP
CUSIP G38648120 | United States | *W EXP 08/29/202 | 336,404 | 335,027 | -1,377 | $137,926 | $110,559 | -$27,367 |
|---|
ARMADA ACQUISITION CORP II
CUSIP G0R38G112 | United States | *W EXP 05/21/203 | 100,000 | 99,942 | -58 | $82,000 | $59,965 | -$22,035 |
|---|
HEARTSCIENCES INC
CUSIP 42254E112 | — | *W EXP 06/15/202 | 195,559 | 192,587 | -2,972 | $8,820 | $21,955 | +$13,135 |
|---|
ABLE VIEW GLOBAL INC
CUSIP G1149B116 | — | *W EXP 08/18/202 | 228,063 | 216,418 | -11,645 | $6,568 | $3,571 | -$2,997 |
|---|
LOCAFY LIMITED
CUSIP Q56120142 | — | *W EXP 03/29/202 | 42,363 | 42,361 | -2 | $76,677 | $74,132 | -$2,545 |
|---|
BIOAFFINITY TECHNOLOGIES INC
CUSIP 09076W117 | — | *W EXP 09/07/202 | 23,498 | 19,850 | -3,648 | $7,754 | $6,551 | -$1,203 |
|---|
CAPTIVISION INC
CUSIP G18932114 | — | *W EXP 11/15/202 | 23,117 | 22,759 | -358 | $301 | $1,363 | +$1,062 |
|---|
INNOVATIVE EYEWEAR INC
CUSIP 45791D117 | — | *W EXP 08/16/202 | 28,408 | 28,103 | -305 | $1,026 | $1,835 | +$809 |
|---|
SAVERONE 2014 LTD
CUSIP 80516T113 | — | *W EXP 06/02/202 | 62,727 | 62,581 | -146 | $1,305 | $626 | -$679 |
|---|
BANZAI INTERNATIONAL INC
CUSIP 06682J118 | — | *W EXP 12/14/202 | 190,231 | 174,955 | -15,276 | $2,663 | $2,099 | -$564 |
|---|
APOLLOMICS INC
CUSIP G0411D115 | — | *W EXP 04/01/202 | 58,200 | 57,051 | -1,149 | $646 | $1,141 | +$495 |
|---|
60 DEGREES PHARMACEUTICALS I
CUSIP 83006G112 | — | *W EXP 07/12/202 | 15,574 | 12,400 | -3,174 | $978 | $621 | -$357 |
|---|
ROCKET PHARMACEUTICALS INC
CUSIP 77313F114 | — | *W EXP 09/02/202 | 311,489 | 309,997 | -1,492 | $6,167 | $6,510 | +$343 |
|---|
SHF HOLDINGS INC
CUSIP 824430110 | — | *W EXP 09/28/202 | 13,261 | 11,871 | -1,390 | $503 | $356 | -$147 |
|---|
CLASSOVER HLDGS INC
CUSIP 182744110 | United States | *W EXP 04/03/203 | 30,730 | 29,580 | -1,150 | $369 | $488 | +$119 |
|---|
NEWGENIVF GROUP LIMITED
CUSIP G0544E113 | — | *W EXP 04/03/202 | 29,421 | 29,346 | -75 | $500 | $581 | +$81 |
|---|
KWESST MICRO SYSTEMS INC
CUSIP 501506133 | — | *W EXP 09/01/202 | 25,665 | 25,575 | -90 | $770 | $818 | +$48 |
|---|
XOS INC
CUSIP 98423B116 | — | *W EXP 08/20/202 | 15,219 | 15,119 | -100 | $59 | $50 | -$9 |
|---|